Clinitech Lab (544220)

FAST GROWER

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹44
Market Cap₹10.04 Cr
P/E Ratio21.36
ROCE8.15%
ROE—%
Dividend Yield0%
Profit Growth36.36%
Debt/Equity
Sales Growth24.51%
SectorHealthcare Services

Clinitech Lab trades with a P/E ratio of 21.36, ROCE of 8.15%, profit growth of 36.36%.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer